Navigation Links
Automated, Wearable Kidney Offers Continuous Dialysis
Date:7/26/2008

UCLA team develops device giving patients freedom of movement, better quality of life

SATURDAY, July 26 (HealthDay News) -- An automated artificial kidney that can be worn on the body may one day be to dialysis patients what the insulin pump is to diabetes patients.

The automated, wearable artificial kidney (AWAK) works better than conventional dialysis, according to a paper in the current issue of Clinical and Experimental Nephrology.

"What's really new about it is the patient's freedom," Martin Roberts, co-designer of the device and an assistant professor of clinical medicine at the David Geffen School of Medicine at UCLA and a dialysis consultant with the Veterans Affairs Los Angeles Healthcare system, said in a university news release. "To me, as the inventor, the most important thing for the patients is their freedom. The next important thing is that because it's working all the time instead of intermittently, you can do a much better job of treating the patient. So we expect the patient to feel better and live longer."

UCLA-VA has already signed an exclusive licensing agreement with AWAK Technologies Pte. Ltd., in Singapore, to develop the design.

The AWAK, which is bloodless, improves upon a previous artificial kidney that was portable but not actually wearable. It improves greatly on conventional dialysis, which requires patients to be connected to a machine for hours.

The new machine would function 24/7, as do actual kidneys, so it would present fewer "shocks" to the patient's system.

More information

The National Kidney Foundation has more on dialysis.



-- HealthDay Staff



SOURCE: University of California, Los Angeles, news release, July 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Researchers design model for automated, wearable artificial kidney
2. Quest Diagnostics Chooses Roches Fully Automated, Real-Time HIV-1 Viral Load Monitoring Test For Its Customers in Laboratories Nationwide
3. Realtime Technologies Launches SHIMMER - a Wearable Health Sensor for Both Connected and Wireless Environments
4. Wearable Artificial Kidney Passes Test
5. Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease (ESRD) Reform
6. Kidney transplants less successful at night
7. Global Warming Linked to Heightened Kidney Stone Risk
8. Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements
9. Male kidneys for men only?
10. Molecule Uses Cellular Recycling to Treat Kidney Cancer
11. Stanford researchers find molecule that kills kidney cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... It can be argued that people these days ... members as they do for their human friends and family. As pets have ... highest quality and most innovative pet products has also increased. , For ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center ... recognizing the organization as a top behavioral service provider in the country. The ... quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, one of ... particle counting and sizing services for USP 788 and 789 particulate standards compliance. ... as a response to the needs of pharmaceutical and medical device manufacturers, who ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... Vancouver, B.C., Canada (PRWEB) , ... December 06, ... ... Consultants (STC) announce the availability of the newly updated International Audit Protocol Consortium ... world use IAPC EHS audit protocols to understand the scope of their EHS ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
(Date:12/5/2016)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ... an enhanced technology platform designed with the ability to ... Pyxis™ and Alaris™ systems, at this year,s American ... being held in Las Vegas ... that approximately 68 percent of medication errors occur during ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology: